GERD Awareness Week: Chronic liver disease, essential oils for acid reflux, obstructive sleep apnea, scleroderma

Written by Bel Marra Health
Published on

acid refluxThe third week of November has been designated GERD awareness week. Gastroesophageal reflux disease or GERD is a very common disorder that affects millions of Americans today. To bring awareness to this condition around the week of Thanksgiving, GERD sufferers can better recognize the condition and seek treatment as soon as possible.
To better inform our readers bout GERD and its related conditions, we have compiled a list of our best articles on the subject. You will find information on essential oils for acid reflux and how GERD relates to chronic liver disease, kidney disease, obstructive sleep apnea, and scleroderma.

Acid reflux medication associated with chronic liver disease progression

Almost everyone experiences heartburn. It is characterized by the feeling of burning chest pain caused by stomach acid regurgitating up into the esophagus. While most people can avoid getting heartburn symptoms by avoiding foods that trigger it, those who suffer from a more severe form of the condition require the use of gastric acid-reducing medication.

Proton pump inhibitors (PPIs) are powerful drugs used in people suffering from excessive acid reflux. An estimated 10 percent of the general population use PPIs and a new study suggest that these drugs could increase their risk of chronic liver disease. Continue reading

7 essential oils for acid reflux or heartburn

Essential oils can be a good choice for treating heartburn. Almost everyone will experience heartburn (acid reflux) at some point in their lives. It is a feeling of burning pain in the chest that may occur after eating a spicy meal or when lying down. It is estimated that about 40 percent of Americans suffer from heartburn pain at least once a month.

Heartburn is the result of acid reflux that travels through the stomach into the esophagus. It is often described as a burning sensation below the breastbone, resulting in a number of additional symptom such as bloating, difficulty swallowing, and indigestion. Continue reading

GERD and Barrett’s esophagus patients have obstructive sleep apnea, poor sleep quality

Gastroesophageal reflux disorder (GERD) and Barrett’s esophagus (BE) patients have higher rates of obstructive sleep apnea and poor sleep quality. Nearly 20 percent of Americans suffer from GERD, which is chronic heartburn or acid regurgitation. Numerous previous studies have explored the association between GERD and poor sleep quality and have found that GERD patients, on average, have worse sleep, including insomnia, sleep disruptions, and overall low quality of sleep. Continue reading

Scleroderma, a GERD risk due to excess collagen in esophagus

Scleroderma is a gastroesophageal reflux disease (GERD) risk due to excess collagen in the esophagus. Scleroderma (systemic sclerosis) is a condition involving a group of diseases that result in the hardening of the skin and connective tissues. Typically scleroderma affects just the skin, but in some individuals it can also affect structures of the body like blood vessels, causing them to harden.

Scleroderma is considered an autoimmune disease and the body produces excess amounts of collagen. When collagen deposits itself it leads to hardening of the skin and other organs. Continue reading

Kidney disease risk increases with use of certain acid reflux medications

New findings suggest that certain acid reflux medications could increase the risk of kidney disease. The medications are known as proton pump inhibitors (PPI) and are part of the top 10 most popular prescribed medications. The study will be presented at ASN Kidney Week 2015 from November 3rd to 8th at the San Diego Convention Center in San Diego, CA.

The prevalence of kidney disease is on the rise, affecting more than 20 million Americans. Risk factors for kidney disease include diabetes and high blood pressure, but medications can play a role, too. Two recent studies revealed the role of proton pump inhibitors and how they play a part in increasing the risk of kidney disease. Continue reading


Advertisement

On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.

Exit mobile version